Cargando…

Hypofractionated (2.75 Gy per fraction) versus Conventionally Fractionated Primary Radiotherapy for T2N0M0 Carcinoma of the Glottis

Introduction Radiotherapy provides excellent outcome in early stage glottic cancer; however, the optimal radiotherapy dose fractionation remains unknown. Objective To investigate the outcome of patients with T2N0M0 treated with either hypofractionated (HypoFxn) or conventionally fractionated radic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kovarik, Josef, Kelly, Charles, Cunnell, Michelle, Jamil, Fatima, Iqbal, Muhammad Shahid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Thieme Revinter Publicações Ltda. 2022
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9879650/ https://www.ncbi.nlm.nih.gov/pubmed/36714891 http://dx.doi.org/10.1055/s-0042-1745855

Ejemplares similares

Hypofractionated helical tomotherapy (75 Gy at 2.5 Gy per fraction) for localized prostate cancer: long-term analysis of gastrointestinal and genitourinary toxicity
por: Kong, Moonkyoo, et al.
Publicado: (2014)

Hypofractionated radiotherapy for early stage glottic cancer: efficacy of 3.5 Gy per fraction
por: Lee, Tae Hoon, et al.
Publicado: (2022)

Hypofractionated High-Dose Intensity-Modulated Radiotherapy (60 Gy at 2.5 Gy per Fraction) for Recurrent Renal Cell Carcinoma: A Case Report
por: Cho, Jaeho, et al.
Publicado: (2008)

Definitive hypofractionated radiotherapy for early glottic carcinoma: experience of 55Gy in 20 fractions
por: Ermiş, Ekin, et al.
Publicado: (2015)

Pion production in p-p collisions at 0.8, 1.5 and 2.75 Bev
por: Block, M M, et al.
Publicado: (1956)

Sequential chemotherapy followed by radical thoracic radiotherapy (50 Gy in 25 fractions) in limited stage small cell lung cancer
por: Iqbal, Muhammad Shahid, et al.
Publicado: (2020)

Poor local control of ulcerative T1 glottic cancer treated with 2.25-Gy per fraction radiotherapy
por: Oie, Yumi, et al.
Publicado: (2021)

Late G2 vagina toxicity in post-operative endometrial carcinoma is associated with a 68 Gy dose equivalent to 2 Gy per fraction((α/β=3Gy)) at 2 cm(3) of vagina
por: Aguilera, María del Valle, et al.
Publicado: (2018)

Survival outcomes for patients with nasopharyngeal carcinoma in non–endemic region in the UK treated with intensity modulated based radiotherapy 65 Gy in 30 fractions ± weekly cisplatin chemotherapy
por: Iqbal, Muhammad Shahid, et al.
Publicado: (2022)

Exchange mechanism for $\pi^{+}p \rightarrow N^{*++} \rho^{0}$ reaction at 2.75 GeV/c
por: Armenise, N, et al.
Publicado: (1966)

Clinical Outcomes of Dose-Escalated Hypofractionated External Beam Radiation Therapy (5 Gy × 5 Fractions) for Spine Metastasis
por: Shin, Jacob Y., et al.
Publicado: (2022)

Detection of the Omicron BA.2.75 subvariant in Japan
por: Hirotsu, Yosuke, et al.
Publicado: (2023)

Predictive value of Excel forms based on an automatic calculation of dose equivalent in 2 Gy per fraction in adaptive brachytherapy for cervical cancer
por: Cheng, Guanghui, et al.
Publicado: (2020)

Fractional quantum Hall effects in In(0.75)Ga(0.25)As bilayer electron systems observed as “Finger print”
por: Yamada, Syoji, et al.
Publicado: (2019)

Radiotherapy with fraction size of 2.25 Gy in T1-2 laryngeal and hypopharyngeal cancer
por: Karasawa, Kumiko, et al.
Publicado: (2013)

A Comparative Study of Daily 3-Gy Hypofractionated and 1.8-Gy Conventional Breast Irradiation in Early-Stage Breast Cancer
por: Lee, Sea-Won, et al.
Publicado: (2016)

Evasion of neutralising antibodies by omicron sublineage BA.2.75
por: Sheward, Daniel J, et al.
Publicado: (2022)

Protection against Reinfection with the Omicron BA.2.75 Subvariant
por: Chemaitelly, Hiam, et al.
Publicado: (2023)

Single institution outcomes of conventional (1.8–2 Gy/Fr) and hypofractionated (2.5–3 Gy/Fr) RT in OG/GOJ cancers during COVID-19
por: Lee, CL, et al.
Publicado: (2022)

Tris(6-carboxypyridine-2-carboxylato)terbium(III) 2.75-hydrate
por: Zebret, Soumaila, et al.
Publicado: (2011)

Quasi-two-body processes in the reaction $\pi^{+}$ p -> p $\pi^{+} \pi^{+} \pi^{-} \pi^{0}$ at 2.75 GeV/c
por: Armenise, N, et al.
Publicado: (1965)

Œdema of the Glottis
Publicado: (1905)

Spasm of the Glottis
Publicado: (1909)

Scald of Glottis
por: Cotterill, J. M.
Publicado: (1877)

The Gypsy Database (GyDB) of mobile genetic elements: release 2.0
por: Llorens, Carlos, et al.
Publicado: (2011)

Randomized Pilot Study of 20 Gy in 5 Fractions versus 27 Gy in 3 Fractions Radiotherapy for Treating Painful Bone Metastases: A Single Institution Experience
por: Sakr, Amr, et al.
Publicado: (2020)

Efficacy of Antiviral Agents against the Omicron Subvariant BA.2.75
por: Takashita, Emi, et al.
Publicado: (2022)

Characterization of the enhanced infectivity and antibody evasion of Omicron BA.2.75
por: Cao, Yunlong, et al.
Publicado: (2022)

Neutralization of Omicron Subvariant BA.2.75 after Bivalent Vaccination
por: Chalkias, Spyros, et al.
Publicado: (2022)

Long-term outcomes of moderately hypofractionated radiotherapy (67.5 Gy in 25 fractions) for prostate cancer confined to the pelvis: a single center retrospective analysis
por: Yao, Lihong, et al.
Publicado: (2020)

Acute and sub-acute toxicity profile of ultra-hypofractionated low-dose total skin electron beam with two 4 Gy fractions for cutaneous T cell lymphoma
por: Rolf, Daniel, et al.
Publicado: (2020)

Hypofractionated radiotherapy in ten fractions for postmastectomy patients: a phase II study compared with another hypofractionation schedule with sixteen fractions
por: Jiang, Huayong, et al.
Publicado: (2021)

Measurement of the branching fraction of the decay $B_s^0\to K_S^0 K_S^0$
por: Aaij, Roel, et al.
Publicado: (2020)

Dose reduction trial from 60 Gy in 10 fractions to 54 Gy in 9 fractions schedule in high-dose-rate interstitial brachytherapy for early oral tongue cancer
por: Akiyama, Hironori, et al.
Publicado: (2012)

Comparison of transcriptional profiles in human lymphocyte cells irradiated with (12)C ion beams at 0–2.0 Gy
por: Zhang, Ruifeng, et al.
Publicado: (2019)

Nonadiabatic coupling of the dynamical structure to the superconductivity in YSr(2)Cu(2.75)Mo(0.25)O(7.54) and Sr(2)CuO(3.3)
por: Conradson, Steven D., et al.
Publicado: (2020)

Neutralisation sensitivity of the SARS-CoV-2 omicron BA.2.75 sublineage
por: Gruell, Henning, et al.
Publicado: (2022)

Antigenic characterization of the SARS-CoV-2 Omicron subvariant BA.2.75
por: Wang, Qian, et al.
Publicado: (2022)

Virological characteristics of the SARS-CoV-2 Omicron BA.2.75 variant
por: Saito, Akatsuki, et al.
Publicado: (2022)

Characterization of SARS-CoV-2 Omicron BA.2.75 clinical isolates
por: Uraki, Ryuta, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_efcp65jgmpt2he4oebd096g49v